DDX4 (DEAD box polypeptide 4) colocalizes with cancer stem cell marker CD133 in ovarian cancers

Biochemical and Biophysical Research Communications

Volumn 447, Issue 2, 2014, Pages 315-322

  Kim, Ki Hyung ^a,b   Kang, Yun Jeong ^c   Jo, Jin Ok ^c   Ock, Mee Sun ^c   Moon, Soo Hyun ^a,b   Suh, Dong Soo ^a,b   Yoon, Man Soo ^a,b   Park, Eun Sil ^d   Jeong, Namkung ^e   Eo, Wan Kyu ^f   Kim, Heung Yeol ^a,c   Cha, Hee Jae ^c  

^a Kosin University College of Medicine   (South Korea)

^b Pusan National University Hospital   (South Korea)

^c Kosin University   (South Korea)

^d HARVARD MEDICAL SCHOOL   (United States)

^e The Catholic University of Korea   (South Korea)

^f Kyung Hee University   (South Korea)

Author keywords

Cancer stem cells; CD133; DDX4; Ovarian cancer

Indexed keywords

CD133 ANTIGEN; DEAD BOX POLYPEPTIDE 4; DEAD BOX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CANCER CELL; CANCER STEM CELL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE MICROARRAY;

CANCER STEM CELLS; CD133; DDX4; OVARIAN CANCER;

ADULT; AGED; ANTIGENS, CD; DEAD-BOX RNA HELICASES; FEMALE; GLYCOPROTEINS; HUMANS; MIDDLE AGED; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PEPTIDES; PROTEIN ARRAY ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84899952645     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.144     Document Type: Article

References (35)

1. D.H. Castrillon, B.J. Quade, T.Y. Wang, C. Quigley, and C.P. Crum The human VASA gene is specifically expressed in the germ cell lineage Proc. Natl. Acad. Sci. U.S.A. 97 2000 9585 9590
2. B. Hay, L.Y. Jan, and Y.N. Jan A protein component of Drosophila polar granules is encoded by vasa and has extensive sequence similarity to ATP-dependent helicases Cell 55 1988 577 587
3. P.F. Lasko, and M. Ashburner The product of the Drosophila gene vasa is very similar to eukaryotic initiation factor-4A Nature 335 1988 611 617
4. S. Styhler, A. Nakamura, A. Swan, B. Suter, and P. Lasko Vasa is required for GURKEN accumulation in the oocyte, and is involved in oocyte differentiation and germline cyst development Development 125 1998 1569 1578
5. Y.A. White, D.C. Woods, Y. Takai, O. Ishihara, H. Seki, and J.L. Tilly Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women Nat. Med. 18 2012 413 421
6. A.P. Skubitz, E.P. Taras, K.L. Boylan, N.N. Waldron, S. Oh, A. Panoskaltsis-Mortari, and D.A. Vallera Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression Gynecol. Oncol. 130 2013 579 587
7. H. Hashimoto, T. Sudo, Y. Mikami, M. Otani, M. Takano, H. Tsuda, H. Itamochi, H. Katabuchi, M. Ito, and R. Nishimura Germ cell specific protein VASA is over-expressed in epithelial ovarian cancer and disrupts DNA damage-induced G2 checkpoint Gynecol. Oncol. 111 2008 312 319
8. J.O. Jo, Y.J. Kang, M.S. Ock, H.K. Kleinman, H.K. Chang, and H.J. Cha Thymosin beta4 expression in human tissues and in tumors using tissue microarrays Appl. Immunohistochem. Mol. Morphol. 19 2011 160 167
9. K. Zou, Z. Yuan, Z. Yang, H. Luo, K. Sun, L. Zhou, J. Xiang, L. Shi, Q. Yu, Y. Zhang, R. Hou, and J. Wu Production of offspring from germline stem cell line derived from neonatal ovaries Nat. Cell. Biol. 11 2009 631 636
10. H.J. Cha, M.J. Jeong, and H.K. Kleinman Role of thymosin beta4 in tumor metastasis and angiogenesis J. Natl. Cancer Inst. 95 2003 1674 1680
11. L. Turnpenny, C.M. Spalluto, R.M. Perrett, M. O'Shea, K.P. Hanley, I.T. Cameron, D.I. Wilson, and N.A. Hanley Evaluating human embryonic germ cells: concord and conflict as pluripotent stem cells Stem Cells 24 2006 212 220
12. U. Karsten, and S. Goletz What makes cancer stem cell markers different? Springerplus 2 2013 301
13. U. Gunthert, M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells Cell 65 1991 13 24
14. P. Marcato, C.A. Dean, D. Pan, R. Araslanova, M. Gillis, M. Joshi, L. Helyer, L. Pan, A. Leidal, S. Gujar, C.A. Giacomantonio, and P.W. Lee Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis Stem Cells 29 2011 32 45
15. M. Zoller CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer 11 2011 254 267
16. M.D. Curley, V.A. Therrien, C.L. Cummings, P.A. Sergent, C.R. Koulouris, A.M. Friel, D.J. Roberts, M.V. Seiden, D.T. Scadden, B.R. Rueda, and R. Foster CD133 expression defines a tumor initiating cell population in primary human ovarian cancer Stem Cells 27 2009 2875 2883
17. M.Y. Fong, and S.S. Kakar The role of cancer stem cells and the side population in epithelial ovarian cancer Histol. Histopathol. 25 2010 113 120
18. A.P. Kusumbe, A.M. Mali, and S.A. Bapat CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature Stem Cells 27 2009 498 508
19. T. Liu, W. Cheng, D. Lai, Y. Huang, and L. Guo Characterization of primary ovarian cancer cells in different culture systems Oncol. Rep. 23 2010 1277 1284
20. M.G. Slomiany, L. Dai, L.B. Tolliver, G.D. Grass, Y. Zeng, and B.P. Toole Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides Clin. Cancer Res. 15 2009 7593 7601
21. S.A. Cannistra, B. DeFranzo, J. Niloff, and C. Ottensmeir Functional heterogeneity of CD44 molecules in ovarian cancer cell lines Clin. Cancer Res. 1 1995 333 342
22. A.H. Yin, S. Miraglia, E.D. Zanjani, G. Almeida-Porada, M. Ogawa, A.G. Leary, J. Olweus, J. Kearney, and D.W. Buck AC133, a novel marker for human hematopoietic stem and progenitor cells Blood 90 1997 5002 5012
23. D. Corbeil, K. Roper, A. Hellwig, M. Tavian, S. Miraglia, S.M. Watt, P.J. Simmons, B. Peault, D.W. Buck, and W.B. Huttner The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions J. Biol. Chem. 275 2000 5512 5520
24. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cusimano, and P.B. Dirks Identification of human brain tumour initiating cells Nature 432 2004 396 401
25. T.X. Liu, M.W. Becker, J. Jelinek, W.S. Wu, M. Deng, N. Mikhalkevich, K. Hsu, C.D. Bloomfield, R.M. Stone, D.J. DeAngelo, I.A. Galinsky, J.P. Issa, M.F. Clarke, and A.T. Look Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation Nat. Med. 13 2007 78 83
26. M. Olempska, P.A. Eisenach, O. Ammerpohl, H. Ungefroren, F. Fandrich, and H. Kalthoff Detection of tumor stem cell markers in pancreatic carcinoma cell lines Hepatobiliary Pancreat. Dis. Int. 6 2007 92 97
27. S. Yin, J. Li, C. Hu, X. Chen, M. Yao, M. Yan, G. Jiang, C. Ge, H. Xie, D. Wan, S. Yang, S. Zheng, and J. Gu CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity Int. J. Cancer 120 2007 1444 1450
28. E. Monzani, F. Facchetti, E. Galmozzi, E. Corsini, A. Benetti, C. Cavazzin, A. Gritti, A. Piccinini, D. Porro, M. Santinami, G. Invernici, E. Parati, G. Alessandri, and C.A. La Porta Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential Eur. J. Cancer 43 2007 935 946
29. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res. 65 2005 10946 10951
30. J. Miki, B. Furusato, H. Li, Y. Gu, H. Takahashi, S. Egawa, I.A. Sesterhenn, D.G. McLeod, S. Srivastava, and J.S. Rhim Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens Cancer Res. 67 2007 3153 3161
31. C.A. O'Brien, A. Pollett, S. Gallinger, and J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
32. L. Ricci-Vitiani, D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, and R. De Maria Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
33. G. Ferrandina, G. Bonanno, L. Pierelli, A. Perillo, A. Procoli, A. Mariotti, M. Corallo, E. Martinelli, S. Rutella, A. Paglia, G. Zannoni, S. Mancuso, and G. Scambia Expression of CD133-1 and CD133-2 in ovarian cancer Int. J. Gynecol. Cancer 18 2008 506 514
34. T. Baba, P.A. Convery, N. Matsumura, R.S. Whitaker, E. Kondoh, T. Perry, Z. Huang, R.C. Bentley, S. Mori, S. Fujii, J.R. Marks, A. Berchuck, and S.K. Murphy Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells Oncogene 28 2009 209 218
35. Y.I. Ji, B.Y. Lee, Y.J. Kang, J.O. Jo, S.H. Lee, H.Y. Kim, Y.O. Kim, C. Lee, S.B. Koh, A. Kim, J.Y. Lee, M.H. Jung, M.S. Ock, and H.J. Cha Expression patterns of thymosin beta4 and cancer stem cell marker CD133 in ovarian cancers Pathol. Oncol. Res. 19 2012 237 245